Diabetic Retinopathy Market
Diabetic Retinopathy Market - Global Industry Assessment & Forecast
Segments Covered
- By Type Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy
- By Management Vitrectomy, Anti-VEGF, Intracular Steroid, Laser Surgery
- By Distribution Channel Hospitals and Pharmacies, Ambulatory Surgical Centers, Eye Clinics
- By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 9.1 Billion |
Revenue 2032: | USD 15.1 Billion |
Revenue CAGR (2024 - 2032): | 6.5% |
Fastest Growing Region (2024 - 2032) | Asia Pacific |
Largest Region (2023): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Diabetic Retinopathy Market Segment Analysis
- Diabetic Retinopathy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Diabetic Retinopathy Management Outlook (Revenue, USD Million, 2018 - 2030)
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Diabetic Retinopathy Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
-
North America Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
-
North America Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- U.S.
- U.S. Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- U.S. Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- U.S. Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- U.S. Diabetic Retinopathy Market, by Type
- Canada
- Canada Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Canada Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Canada Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Canada Diabetic Retinopathy Market, by Type
-
Mexico
- Mexico Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Mexico Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Mexico Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Mexico Diabetic Retinopathy Market, by Type
-
North America Diabetic Retinopathy Market, by Type
- Europe
-
Europe Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
-
Europe Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
-
Europe Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- U. K.
- U.K. Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- U.K. Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- U.K. Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- U.K. Diabetic Retinopathy Market, by Type
- France
- France Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- France Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- France Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- France Diabetic Retinopathy Market, by Type
-
Germany
- Germany Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Germany Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Germany Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Germany Diabetic Retinopathy Market, by Type
-
Italy
- Italy Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Italy Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Italy Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Italy Diabetic Retinopathy Market, by Type
-
Spain
- Spain Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Spain Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Spain Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Spain Diabetic Retinopathy Market, by Type
-
Rest of Europe
- Rest of Europe Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Rest of Europe Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Rest of Europe Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Rest of Europe Diabetic Retinopathy Market, by Type
-
Europe Diabetic Retinopathy Market, by Type
- Asia Pacific
-
Asia Pacific Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
-
Asia Pacific Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
-
Asia Pacific Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- China
- China Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- China Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- China Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- China Diabetic Retinopathy Market, by Type
- Japan
- Japan Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Japan Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Japan Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Japan Diabetic Retinopathy Market, by Type
-
Germany
- Germany Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Germany Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Germany Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Germany Diabetic Retinopathy Market, by Type
-
India
- India Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- India Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- India Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- India Diabetic Retinopathy Market, by Type
-
South Korea
- South Korea Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- South Korea Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- South Korea Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- South Korea Diabetic Retinopathy Market, by Type
-
South East Asia
- South East Asia Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- South East Asia Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- South East Asia Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- South East Asia Diabetic Retinopathy Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Rest of Asia Pacific Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Rest of Asia Pacific Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Rest of Asia Pacific Diabetic Retinopathy Market, by Type
-
Asia Pacific Diabetic Retinopathy Market, by Type
- Latin America
-
Latin America Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
-
Latin America Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
-
Latin America Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Brazil
- Brazil Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Brazil Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Brazil Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Brazil Diabetic Retinopathy Market, by Type
- Argentina
- Argentina Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Argentina Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Argentina Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Argentina Diabetic Retinopathy Market, by Type
-
Rest of Latin America
- Rest of Latin America Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Rest of Latin America Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Rest of Latin America Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Rest of Latin America Diabetic Retinopathy Market, by Type
-
Latin America Diabetic Retinopathy Market, by Type
- Middle East & Africa
-
Middle East & Africa Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
-
Middle East & Africa Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
-
Middle East & Africa Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- GCC Countries
- GCC Countries Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- GCC Countries Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- GCC Countries Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- GCC Countries Diabetic Retinopathy Market, by Type
- South Africa
- South Africa Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- South Africa Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- South Africa Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- South Africa Diabetic Retinopathy Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Diabetic Retinopathy Market, by Type
- Proliferative Diabetic Retinopathy
- Non-Proliferative Diabetic Retinopathy
- Rest of Middle East & Africa Diabetic Retinopathy Market, by Management
- Vitrectomy
- Anti-VEGF
- Intracular Steroid
- Laser Surgery
- Rest of Middle East & Africa Diabetic Retinopathy Market, by Distribution Channel
- Hospitals and Pharmacies
- Ambulatory Surgical Centers
- Eye Clinics
- Rest of Middle East & Africa Diabetic Retinopathy Market, by Type
-
Middle East & Africa Diabetic Retinopathy Market, by Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Diabetic Retinopathy in terms of revenue?
-
The global Diabetic Retinopathy valued at USD 9.1 Billion in 2023 and is expected to reach USD 15.1 Billion in 2032 growing at a CAGR of 6.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Bayer AG, ABBVIE Inc, Novartis AG, Alimera Sciences, Genentec Inc, Ampio Pharmaceuticals Inc, Kowa Company Ltd, BCNPeptides, Oxurion NV, Sirnaomics.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.5% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Diabetic Retinopathy include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Diabetic Retinopathy in 2023.